Serina Therapeutics (SER) Other Working Capital Changes (2018 - 2019)

Serina Therapeutics has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $143000.0 for Q4 2025.

• In Q4 2025, Other Working Capital Changes rose 126.34% year-over-year to $143000.0; the TTM figure through Dec 2025 stood at -$673000.0 (down 135.31% YoY), while the FY2025 annual figure was -$673000.0, down 135.31% from the prior year.
• Other Working Capital Changes came in at $44000.0 for Q1 2019 at Serina Therapeutics, down from $150000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.6 million in Q2 2024 to a low of -$711000.0 in Q3 2025.
• Average Other Working Capital Changes over 5 years is -$30550.0, with a median of -$97500.0 recorded in 2021.
• Year-over-year, Other Working Capital Changes soared 6495.12% in 2024 and plunged 903.51% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$78000.0 in 2021, then jumped by 112.82% to $10000.0 in 2022, then sank by 660.0% to -$56000.0 in 2023, then plunged by 869.64% to -$543000.0 in 2024, then jumped by 126.34% to $143000.0 in 2025.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $143000.0 in Q4 2025, -$711000.0 in Q3 2025, and $353000.0 in Q2 2025.